AEK-8241013-3/11/1

Novartis Pharma AG — FEI 3002807772

Refusal Details

Date
March 4, 2025
Country
Switzerland
Product Category
Drugs and Biologics
Product Code
66VDY99 MISCELLANEOUS PATENT MEDICINES, ETC.
Charges
75